12.14
+0.19(+1.59%)
Currency In USD
| Previous Close | 11.95 |
| Open | 12 |
| Day High | 12.19 |
| Day Low | 11.93 |
| 52-Week High | 32.75 |
| 52-Week Low | 10.01 |
| Volume | 19,775 |
| Average Volume | 315,680 |
| Market Cap | 446.17M |
| PE | -3.37 |
| EPS | -3.61 |
| Moving Average 50 Days | 13.32 |
| Moving Average 200 Days | 18.95 |
| Change | 0.22 |
Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire Inc.
Jul 29, 2025 8:05 PM GMT
SUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced tha
Ceribell to Report Second Quarter 2025 Financial Results on August 5, 2025
GlobeNewswire Inc.
Jul 22, 2025 8:05 PM GMT
SUNNYVALE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced tha
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
GlobeNewswire Inc.
Jul 07, 2025 8:42 PM GMT
Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography (EEG) TechnologySUNNYVALE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a leading medical technology company transfor